Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT
Radiology · 01.05.2023 · 307 (3)
DOI: 10.1148/radiol.222422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, erschienen am 01.05.2023. Verfasst von Sohee Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology and Research Institute of Radiology (S.P., S.M.L., J.C., K.H.D., J.B.S.) and Department of Cardiothoracic Surgery (S…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Adenocarcinoma, Lung Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ministry of Science ICT and Future Planning.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Radiology and Research Institute of Radiology (S.P., S.M.L., J.C., K.H.D., J.B.S.) and Department of Cardiothoracic Surgery (S.C.), University of Ulsan College of Medicine, Asan Medical Center, 88…
ORCID-Profile: Sohee Park, Sang Min Lee, Jooae Choe, Sehoon Choi, Joon Beom Seo
Förderung
- Ministry of Science ICT and Future Planning
Zitieren
APA
Park, S., Lee, S. M., Choe, J., Choi, S., Do, K. H., & Seo, J. B. (2023). Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT. Radiology, 307(3). https://doi.org/10.1148/radiol.222422
Vancouver
Park S, Lee SM, Choe J, Choi S, Do KH, Seo JB. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT. Radiology. 2023;307(3). doi:10.1148/radiol.222422
BibTeX
@article{Park2023,
author = {Park, Sohee and Lee, Sang Min and Choe, Jooae and Choi, Sehoon and Do, Kyung-Hyun and Seo, Joon Beom},
title = {Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT},
journal = {Radiology},
year = {2023},
volume = {307},
number = {3},
doi = {10.1148/radiol.222422}
}
EUVIMED